Das, Satyajit2025-04-252025-04-252019Satyajit Das (2019) A Commentary on Lipid Disorder and HDLCholesterol in HIV Patients: Changing Trends. BAOJ HIV 5: 042.http://hdl.handle.net/20.500.14200/7586With the advent of highly active antiretroviral therapy (HAART) there have been remarkable improvements in the survival of HIV patients. However, complications in the form of dyslipidaemia, insulin resistance, bone problems and liver and kidney disorders have been found to be more noticeable compared to AIDS defining illnesses. The continuous exposures of antivirals of different class with different side effects profile have led to a new trend of problems.enMicrobiology. ImmunologyPharmacologyA Commentary on Lipid Disorder and HDL-Cholesterol in HIV Patients: Changing TrendsArticle